SE0201658D0 - Immediate release pharmaceutical formulation - Google Patents
Immediate release pharmaceutical formulationInfo
- Publication number
- SE0201658D0 SE0201658D0 SE0201658A SE0201658A SE0201658D0 SE 0201658 D0 SE0201658 D0 SE 0201658D0 SE 0201658 A SE0201658 A SE 0201658A SE 0201658 A SE0201658 A SE 0201658A SE 0201658 D0 SE0201658 D0 SE 0201658D0
- Authority
- SE
- Sweden
- Prior art keywords
- active ingredient
- sup
- immediate release
- pharmaceutical formulation
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201658A SE0201658D0 (sv) | 2002-05-31 | 2002-05-31 | Immediate release pharmaceutical formulation |
US10/516,423 US20060014734A1 (en) | 2002-05-31 | 2003-05-27 | Immediate release pharmaceutical formulation |
KR10-2004-7019465A KR20050010016A (ko) | 2002-05-31 | 2003-05-27 | 즉시 방출형 약학 제형 |
RU2004133387/15A RU2351314C2 (ru) | 2002-05-31 | 2003-05-27 | Фармацевтический препарат с немедленным высвобождением |
PCT/SE2003/000857 WO2003101423A1 (fr) | 2002-05-31 | 2003-05-27 | Formulation pharmaceutique a liberation immediate |
BR0311363-9A BR0311363A (pt) | 2002-05-31 | 2003-05-27 | Formulação farmacêutica de liberação imediata, uso da mesma, e, método para tratar um distúrbio cardiovascular em um paciente |
SG2006083430A SG172473A1 (en) | 2002-05-31 | 2003-05-27 | Immediate release pharmaceutical formulation |
AU2003241239A AU2003241239B2 (en) | 2002-05-31 | 2003-05-27 | Immediate release pharmaceutical formulation |
UA20041109446A UA82191C2 (uk) | 2002-05-31 | 2003-05-27 | Фармацевтична таблеткова композиція негайного вивільнення |
CNA038124904A CN1655760A (zh) | 2002-05-31 | 2003-05-27 | 速释药物制剂 |
IL16506903A IL165069A0 (en) | 2002-05-31 | 2003-05-27 | Immediate release pharmaceutical formulation |
NZ536739A NZ536739A (en) | 2002-05-31 | 2003-05-27 | Immediate release pharmaceutical formulation |
EP03730964A EP1513496A1 (fr) | 2002-05-31 | 2003-05-27 | Formulation pharmaceutique a liberation immediate |
NZ549273A NZ549273A (en) | 2002-05-31 | 2003-05-27 | Immediate release pharmaceutical formulation |
MXPA04011943A MXPA04011943A (es) | 2002-05-31 | 2003-05-27 | Formulacion farmaceutica de liberacion inmediata. |
CA002485533A CA2485533A1 (fr) | 2002-05-31 | 2003-05-27 | Formulation pharmaceutique a liberation immediate |
JP2004508781A JP4537197B2 (ja) | 2002-05-31 | 2003-05-27 | 即時放出性医薬製剤 |
PL03373908A PL373908A1 (en) | 2002-05-31 | 2003-05-27 | Immediate release pharmaceutical formulation |
ARP030101933A AR039935A1 (es) | 2002-05-31 | 2003-05-30 | Formulacion farmaceutica de liberacion inmediata |
TW092114804A TWI311555B (en) | 2002-05-31 | 2003-05-30 | Immediate release pharmaceutical formulation |
TW096117054A TW200735864A (en) | 2002-05-31 | 2003-05-30 | Immediate release pharmaceutical formulation |
SA03240403A SA03240403B1 (ar) | 2002-05-31 | 2003-11-30 | تصنيع املاح حمض سيلفونيك ذات انبعاث فوري واستخدامها في علاج الاضطرابات القلبية الوعائية |
NO20044810A NO20044810L (no) | 2002-05-31 | 2004-11-04 | Farmasoytisk formulering med oyeblikkelig frigjoring |
ZA200409237A ZA200409237B (en) | 2002-05-31 | 2004-11-17 | Immediate release pharmaceutical formulation. |
IS7582A IS7582A (is) | 2002-05-31 | 2004-12-03 | Hraðlosandi lyfjablanda |
RU2008141850/15A RU2008141850A (ru) | 2002-05-31 | 2008-10-23 | Жидкий фармацевтический препарат с немедленным высвобождением |
CL2008003324A CL2008003324A1 (es) | 2002-05-31 | 2008-11-07 | Formulacion farmaceutica liquida de liberacion inmediata que comprende una sal de adicion de acido de un compuesto derivado de azetidina sustituido y un diluyente o portador farmaceuticamente aceptable, util para el tratamiento o prevencion de trombosis. |
AU2010200821A AU2010200821A1 (en) | 2002-05-31 | 2010-03-03 | Immediate release pharmaceutical formulation |
JP2010100905A JP2010209090A (ja) | 2002-05-31 | 2010-04-26 | 即時放出性医薬製剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201658A SE0201658D0 (sv) | 2002-05-31 | 2002-05-31 | Immediate release pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0201658D0 true SE0201658D0 (sv) | 2002-05-31 |
Family
ID=20288036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0201658A SE0201658D0 (sv) | 2002-05-31 | 2002-05-31 | Immediate release pharmaceutical formulation |
Country Status (24)
Country | Link |
---|---|
US (1) | US20060014734A1 (fr) |
EP (1) | EP1513496A1 (fr) |
JP (2) | JP4537197B2 (fr) |
KR (1) | KR20050010016A (fr) |
CN (1) | CN1655760A (fr) |
AR (1) | AR039935A1 (fr) |
AU (2) | AU2003241239B2 (fr) |
BR (1) | BR0311363A (fr) |
CA (1) | CA2485533A1 (fr) |
CL (1) | CL2008003324A1 (fr) |
IL (1) | IL165069A0 (fr) |
IS (1) | IS7582A (fr) |
MX (1) | MXPA04011943A (fr) |
NO (1) | NO20044810L (fr) |
NZ (1) | NZ536739A (fr) |
PL (1) | PL373908A1 (fr) |
RU (2) | RU2351314C2 (fr) |
SA (1) | SA03240403B1 (fr) |
SE (1) | SE0201658D0 (fr) |
SG (1) | SG172473A1 (fr) |
TW (2) | TWI311555B (fr) |
UA (1) | UA82191C2 (fr) |
WO (1) | WO2003101423A1 (fr) |
ZA (1) | ZA200409237B (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
AR034517A1 (es) | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
SE0201659D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
CN101528215B (zh) * | 2006-10-20 | 2011-10-19 | 艾科斯有限公司 | Chk1抑制剂和环糊精的组合物 |
TW200827336A (en) | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
TW200900033A (en) * | 2007-06-21 | 2009-01-01 | Wen-Qing Li | Automatic brewing machine |
US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
US9927801B2 (en) | 2012-05-11 | 2018-03-27 | D.P. Technology Corp. | Automatic method for milling complex channel-shaped cavities via coupling flank-milling positions |
US8977382B2 (en) * | 2012-05-11 | 2015-03-10 | D.P. Technology Corp. | Automatic method for milling complex channel-shaped cavities |
CN102827053A (zh) * | 2012-09-20 | 2012-12-19 | 天津嘉宏科技有限公司 | 芳族脒衍生物,其制备方法及作为药物的用途 |
NZ727818A (en) | 2014-06-03 | 2020-06-26 | Idorsia Pharmaceuticals Ltd | Pyrazole compounds and their use as t-type calcium channel blockers |
SG11201701998XA (en) | 2014-09-15 | 2017-04-27 | Actelion Pharmaceuticals Ltd | Triazole compounds as t-type calcium channel blockers |
CN110072521B (zh) | 2016-12-16 | 2022-11-29 | 爱杜西亚药品有限公司 | 包含t型钙通道阻断剂的药物组合 |
ES2971626T3 (es) | 2017-02-06 | 2024-06-06 | Idorsia Pharmaceuticals Ltd | Un proceso novedoso para la síntesis de 1-aril-1-trifluorometilciclopropanos |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252566A (en) * | 1991-11-12 | 1993-10-12 | Eli Lilly And Company | Antithrombotic agents |
SA96170106A (ar) * | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
SE9601556D0 (sv) * | 1996-04-24 | 1996-04-24 | Astra Ab | New pharmaceutical formulation of a thrombin inhibitor for parenteral use |
US5863929A (en) * | 1996-06-25 | 1999-01-26 | Eli Lilly And Company | Anticoagulant agents |
SE9704401D0 (sv) * | 1997-11-28 | 1997-11-28 | Astra Ab | Matrix pellets for greasy, oily or sticky drug substances |
SE9802973D0 (sv) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
CA2345641A1 (fr) * | 1998-09-28 | 2000-04-06 | Merck & Co., Inc. | Procede de traitement de maladies inflammatoires par administration d'un inhibiteur de la thrombine |
WO2000042059A1 (fr) * | 1999-01-13 | 2000-07-20 | Astrazeneca Ab | Nouveaux derives d'amidinobenzylamine et leur utilisation comme inhibiteurs de thrombine |
SI1311480T1 (sl) * | 2000-08-16 | 2008-12-31 | Astrazeneca Ab | Novi amidino derivati in njihova uporaba kot trombinski inhibitorji |
AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
SE0201659D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
-
2002
- 2002-05-31 SE SE0201658A patent/SE0201658D0/xx unknown
-
2003
- 2003-05-27 CA CA002485533A patent/CA2485533A1/fr not_active Abandoned
- 2003-05-27 CN CNA038124904A patent/CN1655760A/zh active Pending
- 2003-05-27 NZ NZ536739A patent/NZ536739A/en not_active IP Right Cessation
- 2003-05-27 RU RU2004133387/15A patent/RU2351314C2/ru not_active IP Right Cessation
- 2003-05-27 BR BR0311363-9A patent/BR0311363A/pt not_active IP Right Cessation
- 2003-05-27 MX MXPA04011943A patent/MXPA04011943A/es active IP Right Grant
- 2003-05-27 PL PL03373908A patent/PL373908A1/xx unknown
- 2003-05-27 UA UA20041109446A patent/UA82191C2/uk unknown
- 2003-05-27 SG SG2006083430A patent/SG172473A1/en unknown
- 2003-05-27 AU AU2003241239A patent/AU2003241239B2/en not_active Ceased
- 2003-05-27 EP EP03730964A patent/EP1513496A1/fr not_active Withdrawn
- 2003-05-27 WO PCT/SE2003/000857 patent/WO2003101423A1/fr active Application Filing
- 2003-05-27 IL IL16506903A patent/IL165069A0/xx unknown
- 2003-05-27 KR KR10-2004-7019465A patent/KR20050010016A/ko not_active Application Discontinuation
- 2003-05-27 JP JP2004508781A patent/JP4537197B2/ja not_active Expired - Fee Related
- 2003-05-27 US US10/516,423 patent/US20060014734A1/en not_active Abandoned
- 2003-05-30 TW TW092114804A patent/TWI311555B/zh active
- 2003-05-30 AR ARP030101933A patent/AR039935A1/es not_active Application Discontinuation
- 2003-05-30 TW TW096117054A patent/TW200735864A/zh unknown
- 2003-11-30 SA SA03240403A patent/SA03240403B1/ar unknown
-
2004
- 2004-11-04 NO NO20044810A patent/NO20044810L/no not_active Application Discontinuation
- 2004-11-17 ZA ZA200409237A patent/ZA200409237B/en unknown
- 2004-12-03 IS IS7582A patent/IS7582A/is unknown
-
2008
- 2008-10-23 RU RU2008141850/15A patent/RU2008141850A/ru unknown
- 2008-11-07 CL CL2008003324A patent/CL2008003324A1/es unknown
-
2010
- 2010-03-03 AU AU2010200821A patent/AU2010200821A1/en not_active Abandoned
- 2010-04-26 JP JP2010100905A patent/JP2010209090A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20060014734A1 (en) | 2006-01-19 |
UA82191C2 (uk) | 2008-03-25 |
PL373908A1 (en) | 2005-09-19 |
EP1513496A1 (fr) | 2005-03-16 |
ZA200409237B (en) | 2005-07-14 |
IL165069A0 (en) | 2005-12-18 |
AR039935A1 (es) | 2005-03-09 |
CA2485533A1 (fr) | 2003-12-11 |
NO20044810L (no) | 2005-02-24 |
NZ536739A (en) | 2006-10-27 |
MXPA04011943A (es) | 2005-03-31 |
JP4537197B2 (ja) | 2010-09-01 |
TW200400940A (en) | 2004-01-16 |
SG172473A1 (en) | 2011-07-28 |
CL2008003324A1 (es) | 2009-03-06 |
RU2004133387A (ru) | 2005-07-10 |
IS7582A (is) | 2004-12-03 |
TW200735864A (en) | 2007-10-01 |
RU2351314C2 (ru) | 2009-04-10 |
AU2003241239A1 (en) | 2003-12-19 |
KR20050010016A (ko) | 2005-01-26 |
JP2005536471A (ja) | 2005-12-02 |
RU2008141850A (ru) | 2010-04-27 |
CN1655760A (zh) | 2005-08-17 |
AU2010200821A1 (en) | 2010-03-25 |
TWI311555B (en) | 2009-07-01 |
WO2003101423A1 (fr) | 2003-12-11 |
JP2010209090A (ja) | 2010-09-24 |
SA03240403B1 (ar) | 2008-12-23 |
AU2003241239B2 (en) | 2010-03-18 |
BR0311363A (pt) | 2005-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0201659D0 (sv) | Modified release pharmaceutical formulation | |
SE0201658D0 (sv) | Immediate release pharmaceutical formulation | |
TNSN03110A1 (fr) | Azaindoles. | |
HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
SE0202463D0 (sv) | Novel compounds | |
UA74391C2 (uk) | Арил- або гетероарилконденсовані імідазоли як антизапальні і анальгетичні агенти | |
GB0005357D0 (en) | Compounds | |
IS2598B (is) | Þíenópýrimidíndíón og notkun þeirra í mótun sjálfnæmissjúkdóma | |
MXPA02012033A (es) | Derivados de 2-aminocarbonil-9h-purina. | |
CY1110593T1 (el) | Η χρηση φαρμακευτικης συνθεσης που περιεχει παραγωγο παρα - αμινοφαινυλοξικου οξεος για τη θεραπεια των φλεγμονωδων καταστασεων του γαστρεντερικου σωληνα | |
RS51200B (sr) | (imidazol-1-il-metil)-piridazin kao blokator nmda receptora | |
EP1340755A4 (fr) | Agents de traitement des infections a helicobacter | |
NO20101069L (no) | Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva | |
AU2001235838A1 (en) | Imidazol derivatives as raf kinase inhibitors | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
SE0302572D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
ATE337827T1 (de) | N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel | |
BG106520A (en) | Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity | |
MX9206930A (es) | Nuevos compuestos | |
HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
RS20050954A (en) | Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | |
HK1075656A1 (en) | New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds | |
DK601983A (da) | Aminoethoxybenzylalkoholderivater | |
MXPA05004842A (es) | Formulacion oromucosal y proceso para su preparacion. |